abstract |
Compounds of formula (I) are described wherein R1, R2, R3, R4, A, m and n are as defined, compositions comprising them, process for their preparation and use in medical therapy (eg, modulation of the activity of the CCR5 receptor in a warm-blooded animal) (see formula (I)). |